Pathogens | Free Full-Text | Pseudomonas aeruginosa Infections in Cancer Patients - Pseudomonas aeruginosa Infections
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine - Pseudomonas aeruginosa
Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment - ScienceDirect - Pseudomonas aeruginosa: Infections and
Antimicrobial agents with activity against Pseudomonas aeruginosa... | Download Scientific Diagram - against Pseudomonas aeruginosa
A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds | Scientific Reports - Pseudomonas aeruginosa
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen - Ceftazidime-avibactam or best available
Original and modified antibiotic reporting panels for Pseudomonas... | Download Scientific Diagram - modified antibiotic reporting panels
Nonantibiotic prevention and management of recurrent urinary tract infection | Nature Reviews Urology - recurrent urinary tract infection
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial - The Lancet Infectious Diseases - treating urinary tract infections
Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study | Infectious Diseases and Therapy - Drug-Resistant Pseudomonas aeruginosa
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports - drug-resistant Pseudomonas aeruginosa
-
Antibiotics | Free Full-Text | The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings - Drug-Resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Treatment of Urinary Tract Infections in Children - Treatment of Urinary Tract Infections
Lower Urinary Tract Infection – Zero To Finals - Lower Urinary Tract Infection – Zero To
Studies regarding the effect of new antibiotics on Pseudomonas... | Download Table - antibiotics on Pseudomonas
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections | BMC Microbiology | Full Text - Pseudomonas aeruginosa infections
Analytical methods for the characterization and diagnosis of infection with Pseudomonas aeruginosa: A critical review - ScienceDirect - Pseudomonas aeruginosa
New treatments in development for Pseudomonas aeruginosa infections in | ODRR - Pseudomonas aeruginosa infections
Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children | BMC Infectious Diseases | Full Text - Pseudomonas aeruginosa bloodstream
Pseudomonas aeruginosa Infection | HAI | CDC - Pseudomonas aeruginosa Infection | HAI
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review - ScienceDirect - Pseudomonas aeruginosa
Emergence and prevention measures for multidrug resistant Pseudomonas aeruginosa in catheter-associated urinary tract infection in spinal cord injury patients | Spinal Cord - urinary tract infection
Antibiotics used for the Treatment of Pseudomonas Aeruginosa | GrepMed - Pseudomonas Aeruginosa | GrepMed
-
A Study List For Pharmacy Students: Antibiotics That Can Cover Pseudomonas and/or MRSA - Antibiotics That Can Cover Pseudomonas
Combinatorial Drug Therapy for Controlling Pseudomonas aeruginosa and Its Association With Chronic Condition of Diabetic Foot Ulcer - Prakhar Srivastava, Karthikeyan Sivashanmugam, 2020 - Diabetic Foot Ulcer
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update | Drugs - Pseudomonas aeruginosa Infections
Pseudomonas Aeruginosa Infection, Symptoms and Treatment - Pseudomonas Aeruginosa Infection
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance - ScienceDirect - Pseudomonas aeruginosa infections
Pseudomonas | Concise Medical Knowledge - Pseudomonas | Concise Medical Knowledge
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial - The Lancet Infectious Diseases - Pseudomonas aeruginosa (PhagoBurn
PDF) Pseudomonas Aeruginosa Urinary Tract Infection in Children: Risk Factors and Outcomes - Pseudomonas Aeruginosa Urinary Tract
Systemic infection facilitates transmission of Pseudomonas aeruginosa in mice | Nature Communications - Pseudomonas aeruginosa in mice
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems | Infection - Treatment options for K. pneumoniae, P
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review | Annals of Clinical Microbiology and Antimicrobials | Full Text - against Pseudomonas aeruginosa biofilms
Antibiotics | Free Full-Text | Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections - against Pseudomonas aeruginosa Infections
-
The proportion of MDR Pseudomonas aeruginosa to all P. aeruginosa... | Download Table - MDR Pseudomonas aeruginosa
Microbe of the month: Pseudomonas aeruginosa: Trends in Microbiology - Pseudomonas aeruginosa
Differentiating and Treating Urinary Tract Infections - Urinary Tract Infections
Current Treatment of Pseudomonal Infections in the Elderly | Drugs & Aging - Pseudomonal Infections in the Elderly
Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis | European Respiratory Society - Pseudomonas aeruginosa infections
Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa - ScienceDirect - Effectiveness of ceftazidime-avibactam
Pseudomonas infections: Causes, symptoms, and treatments - Pseudomonas infections: Causes
Pseudomonas aeruginosa in premise plumbing of large buildings - Bédard - 2016 - MicrobiologyOpen - Wiley Online Library - Pseudomonas aeruginosa in premise
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging - Global Pseudomonas Aeruginosa Infection
Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study | Annals of Clinical Microbiology and Antimicrobials | Full - Influence of borderline cefepime MIC on
Differentiating and Treating Urinary Tract Infections - Urinary Tract Infections
Current Treatment of Pseudomonal Infections in the Elderly | Drugs & Aging - Pseudomonal Infections in the Elderly